BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19890396)

  • 1. Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa.
    Ioerger TR; Koo S; No EG; Chen X; Larsen MH; Jacobs WR; Pillay M; Sturm AW; Sacchettini JC
    PLoS One; 2009 Nov; 4(11):e7778. PubMed ID: 19890396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.
    Müller B; Chihota VN; Pillay M; Klopper M; Streicher EM; Coetzee G; Trollip A; Hayes C; Bosman ME; Gey van Pittius NC; Victor TC; Gagneux S; van Helden PD; Warren RM
    PLoS One; 2013; 8(8):e70919. PubMed ID: 24058399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant tuberculosis in panama is driven by clonal expansion of a multidrug-resistant Mycobacterium tuberculosis strain related to the KZN extensively drug-resistant M. tuberculosis strain from South Africa.
    Lanzas F; Karakousis PC; Sacchettini JC; Ioerger TR
    J Clin Microbiol; 2013 Oct; 51(10):3277-85. PubMed ID: 23884993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
    Pillay M; Sturm AW
    Clin Infect Dis; 2007 Dec; 45(11):1409-14. PubMed ID: 17990220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-detection history of extensively drug-resistant tuberculosis in KwaZulu-Natal, South Africa.
    Brown TS; Challagundla L; Baugh EH; Omar SV; Mustaev A; Auld SC; Shah NS; Kreiswirth BN; Brust JCM; Nelson KN; Narechania A; Kurepina N; Mlisana K; Bonneau R; Eldholm V; Ismail N; Kolokotronis SO; Robinson DA; Gandhi NR; Mathema B
    Proc Natl Acad Sci U S A; 2019 Nov; 116(46):23284-23291. PubMed ID: 31659018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
    PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Genomic Analysis of Two Clonally Related Multidrug Resistant
    Leung KS; Siu GK; Tam KK; To SW; Rajwani R; Ho PL; Wong SS; Zhao WW; Ma OC; Yam WC
    Front Cell Infect Microbiol; 2017; 7():478. PubMed ID: 29188195
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutations in extensively drug-resistant Mycobacterium tuberculosis that do not code for known drug-resistance mechanisms.
    Motiwala AS; Dai Y; Jones-López EC; Hwang SH; Lee JS; Cho SN; Via LE; Barry CE; Alland D
    J Infect Dis; 2010 Mar; 201(6):881-8. PubMed ID: 20136412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis.
    Naidoo CC; Pillay M
    Clin Microbiol Infect; 2014 Jun; 20(6):O361-9. PubMed ID: 24118525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa.
    Moodley P; Shah NS; Tayob N; Connolly C; Zetola N; Gandhi N; Friedland G; Sturm AW
    PLoS One; 2011; 6(5):e17513. PubMed ID: 21655324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
    Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
    BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    OʼDonnell MR; Pillay M; Pillay M; Werner L; Master I; Wolf A; Mathema B; Coovadia YM; Mlisana K; Horsburgh CR; Padayatchi N
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):536-43. PubMed ID: 25886924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitness-compensatory mutations facilitate the spread of drug-resistant F15/LAM4/KZN and F28 Mycobacterium tuberculosis strains in KwaZulu-Natal, South Africa.
    Naidoo CC; Pillay M
    J Genet; 2017 Sep; 96(4):599-612. PubMed ID: 28947708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.
    Shah NS; Auld SC; Brust JC; Mathema B; Ismail N; Moodley P; Mlisana K; Allana S; Campbell A; Mthiyane T; Morris N; Mpangase P; van der Meulen H; Omar SV; Brown TS; Narechania A; Shaskina E; Kapwata T; Kreiswirth B; Gandhi NR
    N Engl J Med; 2017 Jan; 376(3):243-253. PubMed ID: 28099825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan.
    Ali A; Hasan Z; McNerney R; Mallard K; Hill-Cawthorne G; Coll F; Nair M; Pain A; Clark TG; Hasan R
    PLoS One; 2015; 10(2):e0117771. PubMed ID: 25719196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.
    Salvato RS; Costa ERD; Reis AJ; Schiefelbein SH; Halon ML; Barcellos RB; Unis G; Dias CF; Viveiros M; Portugal I; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR
    Infect Genet Evol; 2020 Mar; 78():104127. PubMed ID: 31783187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
    Wilkinson D; Pillay M; Davies GR; Sturm AW
    Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease].
    Baylan O
    Mikrobiyol Bul; 2011 Jan; 45(1):181-95. PubMed ID: 21341173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.